featured
The Performance of AFP, AFP-L3, and DCP as Biomarkers for the Detection of Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States
Clin. Gastroenterol. Hepatol. 2023 Feb 01;21(2)415-423.e4, N Tayob, F Kanwal, A Alsarraj, R Hernaez, HB El-SeragFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.